{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T06:21:49Z","timestamp":1769926909523,"version":"3.49.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["18HLT05 QUIERO"],"award-info":[{"award-number":["18HLT05 QUIERO"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","doi-asserted-by":"publisher","award":["Charite"],"award-info":[{"award-number":["Charite"]}],"id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Psoriasis vulgaris (PV) is a chronic inflammatory disorder frequently associated with cardiovascular disease (CVD). This study aims to provide a prospective tissue characterization in patients with PV without major CVD using cardiovascular magnetic resonance (CMR).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Patients with PV underwent laboratory assessment, a 12-lead and 24-h ECG, and a CMR exam at a 1.5-T scanner. Scan protocol included assessment of left (LV) and right (RV) ventricular function and strain analysis, native and post-contrast T1 mapping, T2 mapping and late gadolinium enhancement (LGE).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In total, 60 PV patients (median(IQR) age in years: 50.0 (36.0\u201360.8); 34 men (56.7%)) were recruited and compared to 40 healthy volunteers (age in years: 49.5 (37.3\u201357.8); 21 men (53.0%)). No differences were found regarding LV and RV function (<jats:italic>p<\/jats:italic>\u2009=\u20090.78 and <jats:italic>p<\/jats:italic>\u2009=\u20090.75). Global radial and circumferential strains were lower in patients (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 and <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001, respectively). PV had higher global T1 times (1001 (982\u20131026) ms vs. 991 (968\u20131005) ms; <jats:italic>p<\/jats:italic>\u2009=\u20090.01) and lower global T2 times (48 (47\u201349) ms vs. 50 (48\u201351) ms; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001); however, all values were within local reference ranges. Focal non-ischemic fibrosis was observed in 17 (28.3%) PV patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Deep cardiac phenotyping by CMR revealed subclinical myocardial injury in patients with PV without major CVD, despite preserved LV and RV function. Diffuse and focal fibrosis might be the first detectable signs of adverse tissue remodeling leading to reduced circumferential and radial myocardial deformation. In the background of local and systemic immunomodulatory therapy, no signs of myocardial inflammation were detected. The exact impact of immunomodulatory therapies on the myocardium needs to be addressed in future studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Study registration<\/jats:title>\n            <jats:p>ISRCTN71534700<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1007\/s00392-024-02456-9","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T04:02:31Z","timestamp":1715832151000},"page":"1133-1144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Deep cardiac phenotyping by cardiovascular magnetic resonance reveals subclinical focal and diffuse myocardial injury in patients with psoriasis (PSOR-COR study)"],"prefix":"10.1007","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7268-9041","authenticated-orcid":false,"given":"Jan","family":"Gr\u00f6schel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonhard","family":"Grassow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edyta","family":"Blaszczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Lommel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Kokolakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Sabat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanette","family":"Schulz-Menger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"key":"2456_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Schon MP (2015) Psoriasis. Lancet 386:983\u2013994. https:\/\/doi.org\/10.1016\/S0140-6736(14)61909-7","journal-title":"Lancet"},{"key":"2456_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN (2021) Psoriasis. Lancet Lond Engl 397:1301\u20131315. https:\/\/doi.org\/10.1016\/S0140-6736(20)32549-6","journal-title":"Lancet Lond Engl"},{"key":"2456_CR3","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","volume":"157","author":"AW Armstrong","year":"2021","unstructured":"Armstrong AW, Mehta MD, Schupp CW et al (2021) Psoriasis prevalence in adults in the United States. JAMA Dermatol 157:940\u2013946. https:\/\/doi.org\/10.1001\/jamadermatol.2021.2007","journal-title":"JAMA Dermatol"},{"key":"2456_CR4","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi K, Balato A, Enerb\u00e4ck C, Sabat R (2021) Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet Lond Engl 397:754\u2013766. https:\/\/doi.org\/10.1016\/S0140-6736(21)00184-7","journal-title":"Lancet Lond Engl"},{"key":"2456_CR5","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323:1945\u20131960. https:\/\/doi.org\/10.1001\/jama.2020.4006","journal-title":"JAMA"},{"key":"2456_CR6","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s12325-020-01346-6","volume":"37","author":"W Masson","year":"2020","unstructured":"Masson W, Lobo M, Molinero G (2020) Psoriasis and cardiovascular risk: a comprehensive review. Adv Ther 37:2017\u20132033. https:\/\/doi.org\/10.1007\/s12325-020-01346-6","journal-title":"Adv Ther"},{"key":"2456_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2796.2010.02310.x","volume":"270","author":"O Ahlehoff","year":"2011","unstructured":"Ahlehoff O, Gislason GH, Charlot M et al (2011) Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med 270:147\u2013157. https:\/\/doi.org\/10.1111\/j.1365-2796.2010.02310.x","journal-title":"J Intern Med"},{"key":"2456_CR8","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.jacc.2021.02.009","volume":"77","author":"MS Garshick","year":"2021","unstructured":"Garshick MS, Ward NL, Krueger JG, Berger JS (2021) Cardiovascular risk in patients with psoriasis: JACC review topic of the week. J Am Coll Cardiol 77:1670\u20131680. https:\/\/doi.org\/10.1016\/j.jacc.2021.02.009","journal-title":"J Am Coll Cardiol"},{"key":"2456_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/bjd.16885","volume":"180","author":"I Snekvik","year":"2019","unstructured":"Snekvik I, Nilsen TIL, Romundstad PR, Saunes M (2019) Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT study, Norway. Br J Dermatol 180:94\u201399. https:\/\/doi.org\/10.1111\/bjd.16885","journal-title":"Br J Dermatol"},{"key":"2456_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/archdermatol.2009.48","volume":"145","author":"AA Qureshi","year":"2009","unstructured":"Qureshi AA, Choi HK, Setty AR, Curhan GC (2009) Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol 145:379\u2013382. https:\/\/doi.org\/10.1001\/archdermatol.2009.48","journal-title":"Arch Dermatol"},{"key":"2456_CR11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/jamadermatol.2015.6262","volume":"152","author":"AS Lonnberg","year":"2016","unstructured":"Lonnberg AS, Skov L, Skytthe A et al (2016) Association of psoriasis with the risk for type 2 diabetes mellitus and obesity. JAMA Dermatol 152:761\u2013767. https:\/\/doi.org\/10.1001\/jamadermatol.2015.6262","journal-title":"JAMA Dermatol"},{"key":"2456_CR12","doi-asserted-by":"publisher","first-page":"e18227","DOI":"10.1371\/journal.pone.0018227","volume":"6","author":"AW Armstrong","year":"2011","unstructured":"Armstrong AW, Lin SW, Chambers CJ et al (2011) Psoriasis and hypertension severity: results from a case-control study. PLoS One 6:e18227. https:\/\/doi.org\/10.1371\/journal.pone.0018227","journal-title":"PLoS One"},{"key":"2456_CR13","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1365-2133.2008.08707.x","volume":"159","author":"JA Kaye","year":"2008","unstructured":"Kaye JA, Li L, Jick SS (2008) Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 159:895\u2013902. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08707.x","journal-title":"Br J Dermatol"},{"key":"2456_CR14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.amjmed.2009.08.022","volume":"123","author":"AB Kimball","year":"2010","unstructured":"Kimball AB, Guerin A, Latremouille-Viau D et al (2010) Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis. Am J Med 123:350\u2013357. https:\/\/doi.org\/10.1016\/j.amjmed.2009.08.022","journal-title":"Am J Med"},{"key":"2456_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaad.2011.06.035","volume":"67","author":"AB Kimball","year":"2012","unstructured":"Kimball AB, Szapary P, Mrowietz U et al (2012) Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis. J Am Acad Dermatol 67:76\u201385. https:\/\/doi.org\/10.1016\/j.jaad.2011.06.035","journal-title":"J Am Acad Dermatol"},{"key":"2456_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/0003319717699329","volume":"69","author":"G Dattilo","year":"2018","unstructured":"Dattilo G, Imbalzano E, Casale M et al (2018) Psoriasis and cardiovascular risk: correlation between psoriasis and cardiovascular functional indices. Angiology 69:31\u201337. https:\/\/doi.org\/10.1177\/0003319717699329","journal-title":"Angiology"},{"key":"2456_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/ijd.12703","volume":"55","author":"B B\u00fclb\u00fcl \u015een","year":"2016","unstructured":"B\u00fclb\u00fcl \u015een B, Ekiz \u00d6, Rifaio\u011flu EN et al (2016) Assessment of subclinical left ventricular dysfunction in patients with psoriasis by speckle tracking echocardiography: a Speckle Tracking Study. Int J Dermatol 55:158\u2013164. https:\/\/doi.org\/10.1111\/ijd.12703","journal-title":"Int J Dermatol"},{"key":"2456_CR18","doi-asserted-by":"publisher","first-page":"100211","DOI":"10.1016\/j.ajpc.2021.100211","volume":"7","author":"W Zhou","year":"2021","unstructured":"Zhou W, Teklu M, Bui V et al (2021) The relationship between systemic inflammation and increased left ventricular mass is partly mediated by noncalcified coronary artery disease burden in psoriasis. Am J Prev Cardiol 7:100211. https:\/\/doi.org\/10.1016\/j.ajpc.2021.100211","journal-title":"Am J Prev Cardiol"},{"key":"2456_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12968-015-0111-7","volume":"17","author":"N Kawel-Boehm","year":"2015","unstructured":"Kawel-Boehm N, Maceira A, Valsangiacomo-Buechel ER et al (2015) Normal values for cardiovascular magnetic resonance in adults and children. J Cardiovasc Magn Reson 17:29. https:\/\/doi.org\/10.1186\/s12968-015-0111-7","journal-title":"J Cardiovasc Magn Reson"},{"key":"2456_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"DR Messroghli","year":"2017","unstructured":"Messroghli DR, Moon JC, Ferreira VM et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson 19:75. https:\/\/doi.org\/10.1186\/s12968-017-0389-8","journal-title":"J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson"},{"key":"2456_CR21","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","volume":"72","author":"VM Ferreira","year":"2018","unstructured":"Ferreira VM, Schulz-Menger J, Holmvang G et al (2018) Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol 72:3158\u20133176. https:\/\/doi.org\/10.1016\/j.jacc.2018.09.072","journal-title":"J Am Coll Cardiol"},{"key":"2456_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-022-02571-6","author":"M Fenski","year":"2022","unstructured":"Fenski M, Grandy TH, Viezzer D et al (2022) Isotropic 3D compressed sensing (CS) based sequence is comparable to 2D-LGE in left ventricular scar quantification in different disease entities. Int J Cardiovasc Imaging. https:\/\/doi.org\/10.1007\/s10554-022-02571-6","journal-title":"Int J Cardiovasc Imaging"},{"key":"2456_CR23","doi-asserted-by":"publisher","first-page":"e004615","DOI":"10.1161\/CIRCIMAGING.115.004615","volume":"9","author":"L Schmacht","year":"2016","unstructured":"Schmacht L, Traber J, Grieben U et al (2016) Cardiac involvement in myotonic dystrophy type 2 patients with preserved ejection fraction: detection by cardiovascular magnetic resonance. Circ Cardiovasc Imaging 9:e004615. https:\/\/doi.org\/10.1161\/CIRCIMAGING.115.004615","journal-title":"Circ Cardiovasc Imaging"},{"key":"2456_CR24","doi-asserted-by":"publisher","unstructured":"von Knobelsdorff-Brenkenhoff F, J S, S D, et al (2017) Detection and monitoring of acute myocarditis applying quantitative cardiovascular magnetic resonance. Circ Cardiovasc Imaging 10. https:\/\/doi.org\/10.1161\/CIRCIMAGING.116.005242","DOI":"10.1161\/CIRCIMAGING.116.005242"},{"key":"2456_CR25","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.jcmg.2020.01.005","volume":"13","author":"A Birukov","year":"2020","unstructured":"Birukov A, Wiesemann S, Golic M et al (2020) Myocardial evaluation of post-preeclamptic women by CMR: is early risk stratification possible? JACC Cardiovasc Imaging 13:1291\u20131293. https:\/\/doi.org\/10.1016\/j.jcmg.2020.01.005","journal-title":"JACC Cardiovasc Imaging"},{"key":"2456_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12968-021-00812-6","volume":"23","author":"E Blaszczyk","year":"2021","unstructured":"Blaszczyk E, Lim C, Kellman P et al (2021) Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study. J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson 23:130. https:\/\/doi.org\/10.1186\/s12968-021-00812-6","journal-title":"J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson"},{"key":"2456_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1148\/radiol.2351040249","volume":"235","author":"DR Messroghli","year":"2005","unstructured":"Messroghli DR, Bainbridge GJ, Alfakih K et al (2005) Assessment of regional left ventricular function: accuracy and reproducibility of positioning standard short-axis sections in cardiac MR imaging. Radiology 235:229\u2013236. https:\/\/doi.org\/10.1148\/radiol.2351040249","journal-title":"Radiology"},{"key":"2456_CR28","doi-asserted-by":"publisher","first-page":"916922","DOI":"10.3389\/fcvm.2022.916922","volume":"9","author":"J Gr\u00f6schel","year":"2022","unstructured":"Gr\u00f6schel J, Bhoyroo Y, Blaszczyk E et al (2022) Different impacts on the heart after COVID-19 infection and vaccination: insights from cardiovascular magnetic resonance. Front Cardiovasc Med 9:916922. https:\/\/doi.org\/10.3389\/fcvm.2022.916922","journal-title":"Front Cardiovasc Med"},{"key":"2456_CR29","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jaad.2004.04.012","volume":"51","author":"RG Langley","year":"2004","unstructured":"Langley RG, Ellis CN (2004) Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician\u2019s Global Assessment. J Am Acad Dermatol 51:563\u2013569. https:\/\/doi.org\/10.1016\/j.jaad.2004.04.012","journal-title":"J Am Acad Dermatol"},{"key":"2456_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jaad.2019.08.026","volume":"82","author":"B Strober","year":"2020","unstructured":"Strober B, Ryan C, van de Kerkhof P et al (2020) Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council. J Am Acad Dermatol 82:117\u2013122. https:\/\/doi.org\/10.1016\/j.jaad.2019.08.026","journal-title":"J Am Acad Dermatol"},{"key":"2456_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12968-020-00610-6","volume":"22","author":"J Schulz-Menger","year":"2020","unstructured":"Schulz-Menger J, Bluemke DA, Bremerich J et al (2020) Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update. J Cardiovasc Magn Reson 22:19. https:\/\/doi.org\/10.1186\/s12968-020-00610-6","journal-title":"J Cardiovasc Magn Reson"},{"key":"2456_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-07539-5","author":"C Lim","year":"2020","unstructured":"Lim C, Blaszczyk E, Riazy L et al (2020) Quantification of myocardial strain assessed by cardiovascular magnetic resonance feature tracking in healthy subjects-influence of segmentation and analysis software. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-020-07539-5","journal-title":"Eur Radiol"},{"key":"2456_CR33","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ijcard.2013.11.048","volume":"170","author":"P Gargiulo","year":"2014","unstructured":"Gargiulo P, Marsico F, Parente A et al (2014) Ischemic heart disease in systemic inflammatory diseases. An appraisal Int J Cardiol 170:286\u2013290. https:\/\/doi.org\/10.1016\/j.ijcard.2013.11.048","journal-title":"An appraisal Int J Cardiol"},{"key":"2456_CR34","doi-asserted-by":"publisher","first-page":"103037","DOI":"10.1016\/j.autrev.2022.103037","volume":"21","author":"C-Y Cheng","year":"2022","unstructured":"Cheng C-Y, Baritussio A, Giordani AS et al (2022) Myocarditis in systemic immune-mediated diseases: prevalence, characteristics and prognosis A systematic review. Autoimmun Rev 21:103037. https:\/\/doi.org\/10.1016\/j.autrev.2022.103037","journal-title":"Autoimmun Rev"},{"key":"2456_CR35","doi-asserted-by":"publisher","first-page":"e606","DOI":"10.1111\/jdv.16486","volume":"34","author":"M Goldenberg","year":"2020","unstructured":"Goldenberg M, Reynolds M, Smart S et al (2020) A retrospective study of myocardial abnormalities detected on cardiac magnetic resonance imaging among patients with psoriasis compared to inflammatory skin disease controls. J Eur Acad Dermatol Venereol JEADV 34:e606\u2013e608. https:\/\/doi.org\/10.1111\/jdv.16486","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"2456_CR36","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jcmg.2014.12.025","volume":"8","author":"NAB Ntusi","year":"2015","unstructured":"Ntusi NAB, Piechnik SK, Francis JM et al (2015) Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping. JACC Cardiovasc Imaging 8:526\u2013536. https:\/\/doi.org\/10.1016\/j.jcmg.2014.12.025","journal-title":"JACC Cardiovasc Imaging"},{"key":"2456_CR37","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1002\/art.40671","volume":"70","author":"Q Guo","year":"2018","unstructured":"Guo Q, Wu L-M, Wang Z et al (2018) Early detection of silent myocardial impairment in drug-naive patients with new-onset systemic lupus erythematosus: a three-center prospective study. Arthritis Rheumatol Hoboken NJ 70:2014\u20132024. https:\/\/doi.org\/10.1002\/art.40671","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"2456_CR38","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/acr.22181","volume":"66","author":"S Mavrogeni","year":"2014","unstructured":"Mavrogeni S, Sfikakis PP, Gialafos E et al (2014) Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases. Arthritis Care Res 66:104\u2013112. https:\/\/doi.org\/10.1002\/acr.22181","journal-title":"Arthritis Care Res"},{"key":"2456_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1148\/radiol.2017162732","volume":"285","author":"VO Puntmann","year":"2017","unstructured":"Puntmann VO, Isted A, Hinojar R et al (2017) T1 and T2 mapping in recognition of early cardiac involvement in systemic sarcoidosis. Radiology 285:63\u201372. https:\/\/doi.org\/10.1148\/radiol.2017162732","journal-title":"Radiology"},{"key":"2456_CR40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10554-014-0560-3","volume":"31","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Corona-Villalobos CP, Kiani AN et al (2015) Myocardial T2 mapping by cardiovascular magnetic resonance reveals subclinical myocardial inflammation in patients with systemic lupus erythematosus. Int J Cardiovasc Imaging 31:389\u2013397. https:\/\/doi.org\/10.1007\/s10554-014-0560-3","journal-title":"Int J Cardiovasc Imaging"},{"key":"2456_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ijcard.2018.06.099","volume":"270","author":"NAB Ntusi","year":"2018","unstructured":"Ntusi NAB, Francis JM, Sever E et al (2018) Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases. Int J Cardiol 270:253\u2013259. https:\/\/doi.org\/10.1016\/j.ijcard.2018.06.099","journal-title":"Int J Cardiol"},{"key":"2456_CR42","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cjca.2019.06.021","volume":"36","author":"G Makavos","year":"2020","unstructured":"Makavos G, Ikonomidis I, Andreadou I et al (2020) Effects of interleukin 17A inhibition on myocardial deformation and vascular function in psoriasis. Can J Cardiol 36:100\u2013111. https:\/\/doi.org\/10.1016\/j.cjca.2019.06.021","journal-title":"Can J Cardiol"},{"key":"2456_CR43","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1001\/jamadermatol.2016.1984","volume":"152","author":"KF Hjuler","year":"2016","unstructured":"Hjuler KF, Bottcher M, Vestergaard C et al (2016) Association between changes in coronary artery disease progression and treatment with biologic agents for severe psoriasis. JAMA Dermatol 152:1114\u20131121. https:\/\/doi.org\/10.1001\/jamadermatol.2016.1984","journal-title":"JAMA Dermatol"},{"key":"2456_CR44","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1111\/jdv.14951","volume":"32","author":"JJ Wu","year":"2018","unstructured":"Wu JJ, Joshi AA, Reddy SP et al (2018) Anti-inflammatory therapy with tumour necrosis factor inhibitors is associated with reduced risk of major adverse cardiovascular events in psoriasis. J Eur Acad Dermatol Venereol 32:1320\u20131326. https:\/\/doi.org\/10.1111\/jdv.14951","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2456_CR45","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D et al (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation 145:e895\u2013e1032. https:\/\/doi.org\/10.1161\/CIR.0000000000001063","journal-title":"Circulation"},{"key":"2456_CR46","doi-asserted-by":"publisher","first-page":"934","DOI":"10.4081\/monaldi.2018.934","volume":"88","author":"E Gorga","year":"2018","unstructured":"Gorga E, Scodro M, Valentini F et al (2018) Echocardiographic evaluation of diastolic dysfunction in young and healthy patients with psoriasis: a case-control study. Monaldi Arch Chest Dis Arch Monaldi Mal Torace 88:934. https:\/\/doi.org\/10.4081\/monaldi.2018.934","journal-title":"Monaldi Arch Chest Dis Arch Monaldi Mal Torace"},{"key":"2456_CR47","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","volume":"40","author":"B Pieske","year":"2019","unstructured":"Pieske B, Tsch\u00f6pe C, de Boer RA et al (2019) How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 40:3297\u20133317. https:\/\/doi.org\/10.1093\/eurheartj\/ehz641","journal-title":"Eur Heart J"},{"key":"2456_CR48","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","volume":"28","author":"WJ Paulus","year":"2007","unstructured":"Paulus WJ, Tsch\u00f6pe C, Sanderson JE et al (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28:2539\u20132550. https:\/\/doi.org\/10.1093\/eurheartj\/ehm037","journal-title":"Eur Heart J"},{"key":"2456_CR49","doi-asserted-by":"publisher","unstructured":"Zhao H, Huang R, Jiang M, et al (2023) Myocardial tissue-level characteristics\u00a0of adults with metabolically healthy obesity. JACC Cardiovasc Imaging S1936\u2013878X(23)00095\u20135. https:\/\/doi.org\/10.1016\/j.jcmg.2023.01.022","DOI":"10.1016\/j.jcmg.2023.01.022"},{"key":"2456_CR50","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.jid.2023.02.037","volume":"143","author":"S Piaserico","year":"2023","unstructured":"Piaserico S, Papadavid E, Cecere A et al (2023) Coronary microvascular dysfunction in asymptomatic patients with severe psoriasis. J Invest Dermatol 143:1929-1936.e2. https:\/\/doi.org\/10.1016\/j.jid.2023.02.037","journal-title":"J Invest Dermatol"},{"key":"2456_CR51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2019.08.009","volume":"289","author":"S Piaserico","year":"2019","unstructured":"Piaserico S, Osto E, Famoso G et al (2019) Long-term prognostic value of coronary flow reserve in psoriasis patients. Atherosclerosis 289:57\u201363. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.08.009","journal-title":"Atherosclerosis"},{"key":"2456_CR52","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jacc.2008.08.064","volume":"53","author":"A Rudolph","year":"2009","unstructured":"Rudolph A, Abdel-Aty H, Bohl S et al (2009) Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 53:284\u2013291. https:\/\/doi.org\/10.1016\/j.jacc.2008.08.064","journal-title":"J Am Coll Cardiol"},{"key":"2456_CR53","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/j.jcmg.2021.04.011","volume":"14","author":"G Joy","year":"2021","unstructured":"Joy G, Artico J, Kurdi H et al (2021) Prospective case-control study of cardiovascular abnormalities 6 months following mild COVID-19 in healthcare workers. JACC Cardiovasc Imaging 14:2155\u20132166. https:\/\/doi.org\/10.1016\/j.jcmg.2021.04.011","journal-title":"JACC Cardiovasc Imaging"},{"key":"2456_CR54","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.119.044720","volume":"141","author":"MC Williams","year":"2020","unstructured":"Williams MC, Kwiecinski J, Doris M et al (2020) Low-attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction: results from the multicenter SCOT-HEART trial (Scottish Computed Tomography of the HEART). Circulation 141:1452\u20131462. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044720","journal-title":"Circulation"},{"key":"2456_CR55","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1056\/NEJMoa2200963","volume":"386","author":"P Maurovich-Horvat","year":"2022","unstructured":"DISCHARGE Trial Group, Maurovich-Horvat P, Bosserdt M et al (2022) CT or invasive coronary angiography in stable chest pain. N Engl J Med 386:1591\u20131602. https:\/\/doi.org\/10.1056\/NEJMoa2200963","journal-title":"N Engl J Med"},{"key":"2456_CR56","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A et al (2020) 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 41:407\u2013477. https:\/\/doi.org\/10.1093\/eurheartj\/ehz425","journal-title":"Eur Heart J"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-024-02456-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-024-02456-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-024-02456-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T07:05:35Z","timestamp":1756883135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-024-02456-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["2456"],"URL":"https:\/\/doi.org\/10.1007\/s00392-024-02456-9","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,16]]},"assertion":[{"value":"15 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complies with the Declaration of Helsinki and was approved by the institutional ethics committee. Ethical approval was obtained from the local ethics committee of Charit\u00e9 Medical University Berlin (approval number EA1\/130\/21). The study was retrospectively registered (ISRCTN71534700).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}